Expression Of CD25 Antigen On CD34+Cells Is An Independent Predictor Of Survival In Late Stage MDS Patients Treated With Azacitidine

被引：0
|
作者：
Kotsianidis, Ioannis
Miltiades, Paraskevi
Lamprianidou, Eleftheria
Vassilakopoulos, Theodoros
Papageorgiou, Sotirios G.
Galanopoulos, Athanasios G.
Vakalopoulou, Sofia
Garypidou, Vassilia
Spanoudakis, Emmanouil
Papaioannou, Maria
Hadjiharissi, Evdoxia
Papadaki, Helen A.
Tsatalas, Costas
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1508.1508
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1508
引用
收藏
页数：2
相关论文
共 50 条
  • [41] CYTOKINE GENE AND CD25 ANTIGEN EXPRESSION BY PERIPHERAL-BLOOD T-CELLS FROM PATIENTS WITH PRIMARY SJOGRENS-SYNDROME
    VILLARREAL, GM
    ALCOCERVARELA, J
    LLORENTE, L
    AUTOIMMUNITY, 1995, 20 (04) : 223 - 229
  • [42] A distinct expression of various gene subsets in CD34+cells from patients with early and advanced myelodysplastic syndrome
    Vasikova, Alzbeta
    Belickova, Monika
    Budinska, Eva
    Cermak, Jaroslav
    LEUKEMIA RESEARCH, 2010, 34 (12) : 1566 - 1572
  • [43] The expression of CXCR4 is down-regulated on the CD34+cells of patients with myelofibrosis with myeloid metaplasia
    Rosti, Vittorio
    Massa, Margherita
    Vannucchi, Alessandro M.
    Bergamaschi, Gaetano
    Campanelli, Rita
    Pecci, Alessandro
    Viarengo, Glanluca
    Meli, Valentina
    Marchetti, Monia
    Guglielmelli, Paola
    Bruno, Edward
    Xu, Mingjiang
    Hoffman, Ronald
    Barosi, Giovanni
    BLOOD CELLS MOLECULES AND DISEASES, 2007, 38 (03) : 280 - 286
  • [44] An altered Lecam1/ICAM1 ratio on CD34+cells predicts leukemic progression in MDS patients.
    Buccisano, F
    Venditti, A
    Tamburini, A
    Del Poeta, G
    Maurillo, L
    Abruzzese, E
    Scornajenghi, KA
    Amadori, S
    BLOOD, 2001, 98 (11) : 620A - 620A
  • [45] In vitro APG101 leads to an improved erythroid differentiation in primary CD34+cells from patients with myelodysplastic syndrome (MDS)
    Fey, S.
    Oblaender, J.
    Mossner, M.
    Brendel, S.
    Nowak, D.
    Kunz, C.
    Fricke, H.
    Hofmann, W-K
    Nolte, F.
    ONKOLOGIE, 2013, 36 : 125 - 125
  • [46] EXPRESSION OF CD25 AND CD45RB ON CD4+ AND CD8+ CELLS IN CYCLOPHOSPHAMIDE (CY) TREATED RCS5 TUMOR-BEARING SJL MICE
    WRONESMITH, T
    PREPOLEC, M
    VANBUREN, E
    LERMAN, S
    FASEB JOURNAL, 1992, 6 (04): : A1433 - A1433
  • [47] Expression of CDKN1C/p57KIP2 predict loss of proliferative phenotype in CD34+cells and poor prognosis of MDS patients
    Dietrich, S.
    Andrulis, M.
    Benner, A.
    Pellagatti, A.
    Germing, U.
    Baldus, S.
    Radujkovic, A.
    Dreger, P.
    Ho, A. D.
    Luft, T.
    ONKOLOGIE, 2013, 36 : 230 - 230
  • [48] IL-2 receptor (CD25) but not CD40L expression by peripheral blood CD4(+) T cells in patients with SLE.
    Moreno, J
    Rojo, P
    Bonifaz, LC
    Jara, LJ
    Aceves, FJ
    Fraga, A
    Medina, F
    Duarte, C
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1660 - 1660
  • [49] CD52 antigen is expressed at different intensities on tumor cells of patients with chronic lymphocytic leukemia, small lymphocytic lymphoma, mantle cell lymphoma and on CD34+cells
    Klabusay, M.
    Sukova, V.
    Coupek, P.
    Brychtova, Y.
    Mayer, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 464 - 464
  • [50] Analysing Circulating CD34+Cells by FISH Is Representative for the Clone Size in Bone Marrow in MDS Patients Under Different Therapy Modalities.
    Braulke, Friederike
    Schanz, Julie
    Truemper, Lorenz H.
    Haase, Detlef
    BLOOD, 2008, 112 (11) : 932 - 933
12345